Source: Business Wire

Press Release: BioIVT : BioIVT Launches LEUKOMAX XL to Provide Researchers with More Cells from a Single Donor Collection per Volume

WESTBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today launched LEUKOMAX XL, a new leukopak product that provides researchers with a minimum of 15 billion TNC. LEUKOMAX XL features the most cells from a single donor collection per volume, including over 50% more cells per bag than the standard Leukopak Full Paks, and is available through U.S. and U.K. collection sites. "BioIVT is proud to provide direct ac

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Richard Haigh's photo - CEO of BioIVT

CEO

Richard Haigh

CEO Approval Rating

87/100

Read more